Olshan’s Advertising, Marketing & Promotions Practice Group chair Andrew Lustigman and associate Morgan Spina have authored the chapter “United States: Pharmaceutical Advertising” in The Legal 500: Pharmaceutical Advertising Country Comparative Guide, a country-specific Q&A providing an overview of pharmaceutical advertising laws and regulations applicable in the United States. Topics covered in the Q&A include how the advertising of medicines are regulated in the US, self-regulatory codes of practice applying to the advertising of medicines, how to define advertising for regulatory purposes, whether companies are required to have material approval prior to releasing a new drug, and more.
You can read the entire Q&A here.
PartnerMarketers, advertisers, agencies and suppliers, among others, regularly seek Andy’s counsel regarding legal aspects of their advertising and promotional marketing businesses. He’s pragmatic and always looks for ...
AssociateAs a member of Olshan’s Brand Management and Protection Group, Morgan helps guide clients on all facets of brand management, including privacy, advertising and intellectual property optimization, enforcement and defense ...